Cleared Traditional

K981021 - ZEUS ANTI-CARDIOLIPIN IGM TEST SYSTEM (FDA 510(k) Clearance)

Jun 1998
Decision
75d
Days
Class 2
Risk

K981021 is an FDA 510(k) clearance for the ZEUS ANTI-CARDIOLIPIN IGM TEST SYSTEM. This device is classified as a System, Test, Anticardiolipin Immunological (Class II - Special Controls, product code MID).

Submitted by Zeus Scientific, Inc. (Branchburg, US). The FDA issued a Cleared decision on June 2, 1998, 75 days after receiving the submission on March 19, 1998.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.

Submission Details

510(k) Number K981021 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 19, 1998
Decision Date June 02, 1998
Days to Decision 75 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code MID — System, Test, Anticardiolipin Immunological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660